Cigna income statement
In fiscal 2025, Cigna reported revenue of $274.90bn, up 11.2% on the year before, operating income of $9.20bn (a 3.3% margin) and net income of $5.96bn, or $22.18 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 39.8 | 41.8 | 48.7 | 153.6 | 160.4 | 174.1 | 180.5 | 195.3 | 247.1 | 274.9 | 282.4 |
| Cost of revenue | 2.5 | 2.5 | 4.8 | 97.7 | 103.5 | 117.6 | 124.8 | 133.8 | 182.5 | 215.0 | 224.1 |
| Gross profit | 37.4 | 39.4 | 43.9 | 55.9 | 56.9 | 56.5 | 55.7 | 61.5 | 64.6 | 59.9 | 58.3 |
| Selling, general and administrative | 9.8 | 10.0 | 11.9 | 14.1 | 14.1 | 13.0 | 13.2 | 14.8 | 14.8 | 14.6 | 14.2 |
| Operating income | 3.1 | 3.9 | 4.2 | 8.1 | 8.2 | 7.9 | 8.5 | 8.5 | 9.4 | 9.2 | 10.0 |
| Interest expense | 0.3 | 0.2 | 0.5 | 1.6 | 1.4 | 1.3 | 1.3 | 1.4 | 1.5 | 1.4 | 1.4 |
| Income before tax | 3.0 | 3.6 | 3.6 | 6.6 | 10.9 | 6.8 | 8.4 | 5.5 | 5.3 | 7.8 | 8.6 |
| Income tax | 1.1 | 1.4 | 0.9 | 1.5 | 2.4 | 1.4 | 1.6 | 0.1 | 1.5 | 1.5 | 1.7 |
| Net income | 1.9 | 2.2 | 2.6 | 5.1 | 8.5 | 5.4 | 6.7 | 5.2 | 3.4 | 6.0 | 6.4 |
| Diluted EPS | $7.19 | $8.77 | $10.54 | $13.44 | $22.96 | $15.75 | $21.41 | $17.39 | $12.12 | $22.18 | $24.19 |
| Diluted shares (average) | 260m | 255m | 250m | 380m | 368m | 341m | 313m | 297m | 283m | 269m | 265m |
| EBITDA | 3.7 | 4.5 | 4.9 | 11.7 | 11.0 | 10.9 | 11.4 | 11.6 | 12.2 | 12.0 | 12.7 |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 63.7 | 65.6 | 65.5 | 67.2 | 69.7 | 72.5 | 68.5 | 71.7 |
| Cost of revenue | 47.6 | 49.0 | 48.4 | 53.3 | 55.5 | 57.8 | 54.1 | 56.7 |
| Gross profit | 16.1 | 16.6 | 17.1 | 13.9 | 14.2 | 14.7 | 14.4 | 15.0 |
| Selling, general and administrative | 3.6 | 3.9 | 4.2 | 3.4 | 3.4 | 3.6 | 3.7 | 3.5 |
| Operating income | 2.6 | 2.2 | 2.0 | 2.3 | 2.6 | 2.3 | 2.4 | 2.7 |
| Interest expense | 0.4 | 0.4 | 0.4 | 0.3 | 0.4 | 0.3 | 0.4 | 0.4 |
| Income before tax | 1.2 | 2.0 | 1.6 | 2.0 | 2.3 | 1.8 | 2.3 | 2.3 |
| Income tax | 0.4 | 0.5 | 0.2 | 0.4 | 0.3 | 0.5 | 0.4 | 0.4 |
| Net income | 0.7 | 1.4 | 1.3 | 1.5 | 1.9 | 1.2 | 1.7 | 1.7 |
| Diluted EPS | $2.63 | $5.07 | $4.85 | $5.71 | $6.98 | $4.66 | $6.26 | $6.29 |
| EBITDA | 3.2 | 2.8 | 2.6 | 3.0 | 3.3 | 3.1 | 3.0 | 3.3 |
Compare with peers
- CVS Health income statement
- Brightspring Health Services, Inc. income statement
- Labcorp income statement
- DaVita income statement
- Quest Diagnostics income statement
Head to head: CI vs CVSBTSG vs CICI vs LH
More: Health Care Services stocks compared, Health Care sector, rankings of US companies